Ivacaftor, a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator, Enhances Ciprofloxacin Activity Against Pseudomonas aeruginosa

Correlation between sinus and lung cultures in lung transplant patients with cystic fibrosis

(2017) Kevin J. Choi et al.   International Forum of Allergy & Rhinology

Understanding Biofilms in Chronic Sinusitis

(2016) Bobby A. Tajudeen et al.   CURRENT ALLERGY AND ASTHMA REPORTS

Tolerance and pharmacokinetics of a ciprofloxacin-coated sinus stent in a preclinical model

(2016) Do-Yeon Cho et al.   International Forum of Allergy & Rhinology

An “Unlikely” Pair: The Antimicrobial Synergy of Polymyxin B in Combination with the Cystic Fibrosis Transmembrane Conductance Regulator Drugs KALYDECO and ORKAMBI

(2016) Elena K. Schneider et al.   ACS Infectious Diseases

Chronic lung infection by Pseudomonas aeruginosa biofilm is cured by L-Methionine in combination with antibiotic therapy

(2015) Divya Prakash Gnanadhas et al.   Scientific Reports

Impact of the CFTR-Potentiator Ivacaftor on Airway Microbiota in Cystic Fibrosis Patients Carrying A G551D Mutation

(2015) Cédric Bernarde et al.   PLoS One

Management of the upper airway in cystic fibrosis

(2014) Elisa A. Illing et al.   CURRENT OPINION IN PULMONARY MEDICINE

Antibacterial properties of the CFTR potentiator ivacaftor

(2014) Leah R. Reznikov et al.   Journal of Cystic Fibrosis

Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success

(2014) Liam S. Redgrave et al.   TRENDS IN MICROBIOLOGY

Cystic Fibrosis Chronic Rhinosinusitis: A Comprehensive Review

(2013) Mohamad R. Chaaban et al.   American Journal of Rhinology & Allergy

Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis

(2013) Kasper Aanæs   Journal of Cystic Fibrosis

Culture-based diagnostic microbiology in cystic fibrosis: Can we simplify the complexity?

(2013) Jane L. Burns et al.   Journal of Cystic Fibrosis

Optimizing Nasal Potential Difference Analysis for CFTR Modulator Development: Assessment of Ivacaftor in CF Subjects with the G551D-CFTR Mutation

(2013) Steven M. Rowe et al.   PLoS One

Resveratrol Enhances Airway Surface Liquid Depth in Sinonasal Epithelium by Increasing Cystic Fibrosis Transmembrane Conductance Regulator Open Probability

(2013) Shaoyan Zhang et al.   PLoS One

Mechanisms of β-lactam Resistance Among Pseudomonas aeruginosa

(2012) Daniel J. Wolter et al.   CURRENT PHARMACEUTICAL DESIGN

Novel drug-delivery systems for patients with chronic rhinosinusitis

(2012) Silviu Albu   Drug Design Development and Therapy

Recent advances in materials for extended-release antibiotic delivery system

(2011) Ping Gao et al.   JOURNAL OF ANTIBIOTICS

Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype

(2009) D. J. Wolter et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY